EICKHOFF; JAN

Patent Applications and Registrations

Patent applications and USPTO patent grants for EICKHOFF; JAN.The latest application filed is for "pharmaceutically active pyrazolo-triazine and/or pyrazolo-pyrimidine derivatives".

Company Profile

2.15.24

EICKHOFF; JAN - HERDECKE DE
Eickhoff; Jan - Heerdecke DE
Eickhoff; Jan - Munich DE
Eickhoff; Jan - Straubenhardt DE
Eickhoff; Jan - Berlin DE

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Pharmaceutically Active Pyrazolo-triazine And/or Pyrazolo-pyrimidine Derivatives App 20220098208 - NAM; KIYEAN ; et al.	2022-03-31
Pyrazolo-triazine And/or Pyrazolo-pyrimidine Derivatives As Selective Inhibitor Of Cyclin Dependent Kinase App 20210147427 - NAM; KIYEAN ; et al.	2021-05-20
Pharmaceutically Active Pyrazolo-triazine And/or Pyrazolo-pyrimidine Derivatives App 20210139483 - NAM; KIYEAN ; et al.	2021-05-13
Pharmaceutically active pyrazolo-triazine derivatives Grant 9,567,345 - Eickhoff , et al. February 14, 2	2017-02-14
Quinoline inhibitor of the macrophage stimulating 1 receptor MSTR1 Grant 9,481,668 - Schadt , et al. November 1, 2	2016-11-01
Quinoline Inhibitor of the Macrophage Stimulating 1 Receptor MSTR1 App 20160115154 - SCHADT; Oliver ; et al.	2016-04-28
Pharmaceutically active disubstituted pyridine derivatives Grant 9,242,937 - Ruhter , et al. January 26, 2	2016-01-26
Pharmaceutically active disubstituted triazine derivatives Grant 9,226,929 - Ruhter , et al. January 5, 2	2016-01-05
Cdk9 Inhibitors In The Treatment Of Midline Carcinoma App 20150329537 - Choidas; Axel ; et al.	2015-11-19
Pharmaceutically active pyrazolo-triazine derivatives Grant 9,096,608 - Eickhoff , et al. August 4, 2	2015-08-04
Pharmaceutically Active Pyrazolo-triazine Derivatives App 20150111873 - Eickhoff; Jan ; et al.	2015-04-23
Pharmaceutically active compounds as Axl inhibitors Grant 8,999,982 - Schultz-Fademrecht , et al. April 7, 2	2015-04-07
Pharmaceutically Active Pyrazolo-triazine Derivatives App 20150018329 - Eickhoff; Jan ; et al.	2015-01-15
Cdk9 Inhibitors In The Treatment Of Midline Carcinoma App 20140303167 - Choidas; Axel ; et al.	2014-10-09
Pharmaceutically Active Disubstituted Pyridine Derivatives App 20140296304 - Ruhter; Gerd ; et al.	2014-10-02
Susceptibility To Selective Cdk9 Inhibitors App 20140287454 - Choidas; Axel ; et al.	2014-09-25
Pharmaceutically Active Disubstituted Triazine Derivatives App 20140179662 - Ruhter; Gerd ; et al.	2014-06-26
Pharmaceutically Active Compounds As Axl Inhibitors App 20140018365 - Schultz-Fademrecht; Carsten ; et al.	2014-01-16
Pharmaceutically Active Disubstituted Triazine Derivatives App 20130079345 - Eickhoff; Jan ; et al.	2013-03-28
Raf inhibitors Grant 8,232,283 - Schoop , et al. July 31, 2	2012-07-31
Cover with recloseable aperture Grant 8,152,016 - Berndt , et al. April 10, 2	2012-04-10
Pump motor Grant D647,537 - Mehnert , et al. October 25, 2	2011-10-25
Raf Inhibitors App 20110257207 - BACKES; Alexander ; et al.	2011-10-20
Control unit Grant D603,807 - Mehnert , et al. November 10, 2	2009-11-10
Pump Grant D603,870 - Mehnert , et al. November 10, 2	2009-11-10
Control unit Grant D603,343 - Mehnert , et al. November 3, 2	2009-11-03
Microfluidic Device with at Least One Retaining Device App 20080190840 - Eickhoff; Jan ; et al.	2008-08-14
Cover with Recloseable Aperture App 20070257035 - Berndt; Manfred ; et al.	2007-11-08
Parallel processing microfluidic chip App 20070071638 - Kraiczek; Karsten ; et al.	2007-03-29

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.